Evaluate price controls, surplus, and market failure

Linden's baseline chair market clears at $60 and 800 chairs per week. A policy memo proposes a $50 maximum price to help buyers; another proposes a $70 minimum to help sellers. The first memo assumes every buyer gains. The second assumes every seller gains. Both treat a displayed price as a completed incidence analysis.

This lesson tests the rules, computes the short-side quantities and welfare areas, and then asks what those areas leave out.

Test whether the rule binds

A price ceiling is a maximum. It binds in the foundational model only when it is below the equilibrium price that would otherwise apply. A ceiling at or above $60 does not constrain Linden's baseline price; the hypothetical $50 ceiling does.

A price floor is a minimum. It binds only when it is above the applicable equilibrium. A floor at or below $60 does not constrain the baseline price; the hypothetical $70 floor does.

Bindingness is market- and period-specific. A demand or supply shift can move the equilibrium and change whether the same legal number binds. Scope, effective date, covered transaction, quality, exemptions, enforcement, and currency also belong in a real rule analysis.

Complete the ceiling and floor bindingness steps before calculating incidence. The legal label alone does not tell you whether the current model price is constrained.

Use the short side for traded quantity

At the $50 ceiling, baseline quantity demanded is 900 chairs and quantity supplied is 700. The 200-chair difference is a shortage. Without another source of supply, at most 700 units trade in the simple model.

At the $70 floor, quantity supplied is 900 and quantity demanded is 700. The 200-chair difference is a surplus. Without a government or other additional buyer, at most 700 units trade.

Do not multiply controlled price by the long-side quantity and call it revenue. Offered units are not completed sales. Desired units are not completed purchases. Orders, allocation, fulfillment, returns, recognition, receivables, inventory, and cash require separate records.

Incidence needs an allocation mechanism

At the ceiling, some buyers may obtain chairs at the lower posted price. Other buyers may queue, search, pay fees or side payments, accept lower quality, or go without. The posted price is not necessarily their full effective cost.

At the floor, some sellers may complete trades at the higher price. Other sellers may sell nothing, cut production, carry or dispose of output, change quality, or exit. The higher price cannot be applied to every offered unit.

Eligibility, allocation, enforcement, evasion, quality, time, information, bargaining, and adjustment determine who gains and loses. The basic area calculation below assumes efficient rationing: the 700 traded units go to the highest-willingness-to-pay buyers and lowest-reservation-cost sellers. State that assumption every time it is used. It also assumes zero implementation and enforcement cost; any such cost belongs in a separate, evidenced ledger.

Complete both price-control items. A strong answer reports bindingness, imbalance, short side, allocation assumption, omitted effective costs, and the records needed for an accounting conclusion.

Compute consumer surplus over traded units

Consumer surplus is modeled willingness to pay minus the amount paid, summed over traded units. Linden's inverse demand intercept is $140.

At equilibrium:

consumer surplus = 1/2 × ($140 - $60) × 800 = $32,000

Under the $50 ceiling and efficient allocation of 700 units, the area is not the triangle with 900 units. Integrate willingness to pay over the 700 traded units and subtract their $50 payments. The verified result is $38,500.

The floor uses the same 700-unit short side. With inverse demand P = $140 - Q/10, consumer surplus at $70 is:

($140 - $70) × 700 - 700² / 20 = $24,500

That increase belongs to buyers who receive the rationed chairs under the assumption. It says nothing about the 200 units of excess demand or about queue, search, quality, and side costs. Random or preferential allocation can change the result.

Consumer surplus is not a seller asset, revenue, receivable, or cash balance. It is also shaped by ability to pay and does not automatically capture rights, distribution, or nonmarket value.

Compute producer surplus without calling it profit

Producer surplus is the amount received minus the reservation amount represented by the supply relationship, summed over traded units. Linden's inverse supply line has a price intercept of negative $20. That is a mathematical feature of the stipulated line; it is not evidence of a literal transaction at a negative price outside the relevant domain.

At equilibrium:

producer surplus = 1/2 × ($60 - (-$20)) × 800 = $32,000

Under the $70 floor and 700 traded units, verified producer surplus is $38,500. Do not use all 900 units offered. The other 200 are excess supply, not completed transactions.

The ceiling mirror is also explicit. With inverse supply P = -$20 + Q/10, producer surplus at $50 is:

($50 - (-$20)) × 700 - 700² / 20 = $24,500

Producer surplus is not net income. The supply area can omit fixed costs, depreciation, financing, taxes, period expenses, and recognition rules. It is not operating cash flow. Those measures use entity-specific statements and events.

Complete the consumer- and producer-surplus items. Each answer must name the curve interpretation, traded quantity, price, allocation, period, and at least one excluded accounting or distributional claim.

Reconcile total surplus on one scope

Total surplus adds consumer and producer surplus using the same market, units, period, traded quantity, and assumptions. At equilibrium:

$32,000 + $32,000 = $64,000 per modeled week

Under either controlled price in this symmetric example, the verified total is $63,000 under efficient allocation and zero implementation cost.

The components reveal distribution within the scoped buyer-and-seller model. The total supports a narrow efficiency comparison. Neither establishes complete welfare.

Whose willingness to pay is represented? Does ability to pay exclude important needs? Are third-party harms or benefits present? Do rights, quality, risk, information, market power, future periods, or nonmarket values matter? A larger area cannot answer those questions without new evidence and criteria.

Separate redistribution from deadweight loss

Deadweight loss is the reduction in the scoped total-surplus benchmark, not every decrease in one component.

At the $50 ceiling, consumer surplus rises by $6,500 relative to equilibrium while producer surplus falls by $7,500. Much of that component movement is a transfer toward buyers who obtain units. The total falls by $1,000:

deadweight loss = $64,000 - $63,000 = $1,000

At the $70 floor, the component movement reverses while the same $1,000 total difference remains in this symmetric model. The lost amount corresponds to mutually beneficial trades between 700 and 800 chairs that no longer occur under the bounded assumptions.

That equality is a feature of Linden's constructed linear schedules: demand and supply have equal absolute slopes, and the two controls sit the same distance from equilibrium. Different slopes, curvatures, or control distances need not produce equal quantity losses or deadweight loss.

Deadweight loss is not an expense, impairment, liability, or cash outflow on a seller's books. It is a welfare-model difference. A policy can also have administrative cost, revenue, redistribution, rights effects, or external benefits outside that triangle.

Complete the deadweight-loss item by reconciling both totals first. If the answer starts from only the buyer or seller component, it cannot distinguish a transfer from destroyed model surplus.

Second sitting: diagnose market failure before prescribing a remedy

Pause here if the surplus ledger is new. The remaining section is a transfer exercise: it reuses the same discipline of naming a benchmark, calculation, and open evidence, but applies it to institutional alternatives rather than another area computation.

The clean Linden model can clear and maximize its buyer-plus-seller surplus while omitting a relevant effect. Suppose a reviewer alleges that disposal of the chairs causes uncompensated harm to nearby residents. The allegation points to a possible external effect, but no affected population, mechanism, magnitude, causal evidence, legal duty, or remedy cost is supplied.

A reviewable diagnosis states:

1. the market and efficiency or rights benchmark;
2. the omitted effect or violated model assumption;
3. the affected parties and causal pathway;
4. measurement, period, magnitude, uncertainty, and evidence;
5. why existing prices, property rights, contracts, liability, or rules do not internalize the effect; and
6. the margin on which behavior and welfare change.

Only then compare institutions: information, contracts, standards, liability, fees, taxes, subsidies, provision, competition, or enforcement. Each option has administrative cost, information requirements, distribution, evasion, capture, and unintended effects. Market failure does not mean no market exists, and a valid diagnosis does not prove one government intervention is best.

Accounting evidence can support parts of the inquiry, expenditures, obligations, transactions, provisions, contingencies, or asset effects. It may not measure the social cost outside the reporting entity. Do not force every relevant value into a ledger merely because the ledger is available.

Exit check

Prepare a two-column Linden policy note. The model ledger must show equilibrium, bindingness, Qd, Qs, short-side trade, imbalance, allocation, consumer surplus, producer surplus, total surplus, and reconciled deadweight loss. The evidence and judgment ledger must show legal scope, enforcement, effective costs, unserved parties, unsold output, distribution, external effects, rights, transaction and accounting records, alternatives, authority, uncertainty, and revision triggers.

End with a conditional conclusion. Do not call a posted price full incidence, a welfare area an accounting amount, total surplus complete welfare, or a market- failure diagnosis an automatic remedy.